Furthermore, it is even conceivable that a minimally invasive test could potentially also be developed to discern “good” (organ-confined/androgen-dependent disease) and “bad” (metastatic/androgen -independent disease) PCa given the positive correlation between PAGE4 and biochemical recurrence-free survival following radical prostatectomy. The gene discussed is PAGE4; the disease is posterior cortical atrophy.